Viewing Study NCT03675893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-24 @ 12:14 AM
Study NCT ID: NCT03675893
Status: RECRUITING
Last Update Posted: 2025-06-15
First Post: 2018-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Endometrial Cancer View
None CDK4/6 View
None ER+ View
None Estrogen Receptor View
None Low-Grade Serous Ovarian Cancer View
None eIF4A View
None PI3K View
None PAM View